From the Journals

DOACs’ safety affirmed in real-world setting


 

FROM THE BMJ

The study was supported by a grant from the National Institute for Health Research. The investigators had no relevant disclosures.

SOURCE: Vinogradova Y et al. BMJ 2018; 362:K2505.

Pages

Recommended Reading

DEFUSE 3: Thrombectomy time window broadens
MDedge Neurology
VIDEO: COMPASS shows stroke-clot aspiration noninferior to retrieval
MDedge Neurology
VIDEO: Rivaroxaban plus aspirin halves ischemic strokes
MDedge Neurology
Thrombectomy’s success treating strokes prompts rethinking of selection criteria
MDedge Neurology
VIDEO: PFO closure device 100% effective against future strokes
MDedge Neurology
Apixaban prevails in study of 163,000 DOAC users
MDedge Neurology
MDedge Daily News: Which diabetes drug boosts survival best?
MDedge Neurology
Midlife retinopathy predicts ischemic stroke
MDedge Neurology
Amplatzer Amulet slashes stroke risk in A-fib
MDedge Neurology
TAVR-related stroke risk unrelated to anatomy
MDedge Neurology